[Pharmacotherapy in cancer pain management].
Gralow I
Research article (journal)Abstract
Cancer-related pain affects approximately about 30 to 80 % of all patients, according to primary and metastatic sides and stage of disease. Cancer pain management depends on the underlying pathophysiological mechanisms. Current pain treatment is still based on the World Health Organisation (WHO-"ladder") - guidelines, opioid therapy beeing the cornerstone. The present overview article focuses on different opioids, as well as on the various adjuvants. Advantages and side effects of the different nonopioids, anticonvulsants, and antidepressants are discussed. The recommendations are limited for the adult outpatient treatment.
Details about the publication
Journal: Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie (AINS)
Volume: 45
Issue: 1
Page range: 34-42
Status: Published
Release year: 2010
Language in which the publication is written: German
Keywords: Anticonvulsants; Pain; Analgesics Non-Narcotic; Antidepressive Agents; Humans; Analgesics; Drug Therapy Combination; Ambulatory Care; Analgesics Opioid; Neoplasms; Anti-Inflammatory Agents Non-Steroidal; Anticonvulsants; Pain; Analgesics Non-Narcotic; Antidepressive Agents; Humans; Analgesics; Drug Therapy Combination; Ambulatory Care; Analgesics Opioid; Neoplasms; Anti-Inflammatory Agents Non-Steroidal
Authors from the University of Münster
| Gralow, Ingrid | Clinic for Anaesthesiology, Surgical Critical Care Medicine and Pain Therapy |